Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Baudax Bio, Inc. - Common stock (NQ: BXRX )

N/A UNCHANGED
Last Price Updated: 3:50 PM EST, Nov 15, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Baudax Bio, Inc. - Common stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
Crude Oil Down Over 2%; General Motors Raises Profit Outlook
U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping around 100 points on Tuesday. The Dow traded down 0.19% to 33,811.66 while the NASDAQ fell 0.87% to 11,932.83. The... 
Via Benzinga
Baudax Bio's Nerve Blockade Aces Mid-Stage Study In Surgery Patients
Baudax Bio Inc (NASDAQ: BXRX) announced top-line results from its Phase 2 clinical trial of BX1000 for neuromuscular blockade (NMB) in elective surgery patients.  
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Baudax Bio Announces Positive Top-Line Final Results From Phase 2 Randomized Clinical Trial of BX1000
From Baudax Bio, Inc.
Via GlobeNewswire
Baudax Bio to Host Key Opinion Leader Webinar to Discuss Results of Phase 2 BX1000 Trial
Virtual Webinar to be held April 25, 2023 at 10:00 AM Eastern Time 
From Baudax Bio, Inc.
Via GlobeNewswire
Why Baudax Bio Shares Are Trading Higher Today
Via Benzinga
Why Travelers Companies Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) gained 85.2% to $1.25 after the company announced the termination of its previously proposed registered direct offering. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
AstraZeneca-Ionis Partnered Rare Disease Drug Data Shows Sustained Benefit; Drug Under FDA Review
Via Benzinga
Looking Into Baudax Bio's Return On Capital Employed
Via Benzinga
Why Baudax Bio Shares Trading Higher Today
Via Benzinga
Why Is Baudax Bio (BXRX) Stock Up 50% Today?
BXRX stock is soaring today as Baudax Bio's novel medical product could result in time and cost savings for patients and hospitals. 
Via InvestorPlace
Baudax Bio Announces Positive Results from 2nd Interim Analysis of Phase 2 Randomized Trial for BX1000
From Baudax Bio, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Baudax Bio Reports 2022 Fourth Quarter and Annual Financial Results and Provides Business Update
From Baudax Bio, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Why Grom Social Enterprises Shares Are Trading Lower By 30%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) shares surged 85% to $2.2200. Sonoma Pharmaceuticals and EMC Pharma announced Department of Defense DAPA registration for Microcyn(R) Rx products. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Is the Pain Over for Baudax Bio Investors after a 70% Spike?
Baudax Bio (NASDAQ: BXRX) shares spiked as much as 70% on its announcement of positive interim phase 2 clinical trials for its pain medicine BX1000. 
Via MarketBeat
Dow Rises 80 Points; Altamira Therapeutics Shares Plunge
U.S. stocks traded mixed toward the end of trading, with the Dow Jones gaining around 80 points on Tuesday. The Dow traded up 0.24% to 33,710.06 while the NASDAQ fell 0.21% to 11,340.24. The S&P 500... 
Via Benzinga
Why Baudax Bio Shares Are Trading Higher By 60%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Baudax Bio, Inc. (NASDAQ: BXRX) shares surged 59.7% to $5.03 after the company announced the outcome of its first interim analysis in a Phase II trial of BX1000 for neuromuscular blockade in... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Stocks Static As Earnings Season Heats Up
After a strong start to the week, stocks are struggling for direction today as investors unpack the latest batch of earnings reports. 
Via Talk Markets
Dow Edges Higher; Crude Oil Down 1%
U.S. stocks traded mostly flat midway through trading, with the Dow Jones trading slightly higher on Tuesday. The Dow traded up 0.03% to 33,638.42 while the NASDAQ fell 0.07% to 11,356.65. The S&P 500... 
Via Benzinga
Dow Drops 100 Points; Verizon Issues Weak Earnings Forecast
U.S. stocks traded lower this morning, with the Dow Jones dropping more than 100 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.31% to 33,524.12 while the NASDAQ fell... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Baudax Bio Announces Positive Outcome of Interim Analysis of Phase II Randomized Trial for BX1000
From Baudax Bio, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.